IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Altium Capital Management LLC

Q1 2025 Holdings

Filed 2025-05-09 | 24 holdings | $41.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2025-05-13) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Zevra Therapeutics Inc(ZVRA)COM NEW488445206$9.6M1,287,33323.2%
Alnylam Pharmaceuticals Inc(ALNY)PutCOM02043Q107$6.8M25,00016.3%
Evolus Inc(EOLS)COM30052C107$3.6M296,1938.6%
Xtant MED Hldgs Inc(XTNT)COM NEW98420P308$3.4M7,252,9988.2%
Avadel Pharmaceuticals PLCCOM SHSG29687103$3.3M419,1317.9%
Contineum Therapeutics Inc(CTNM)CL A21217B100$2.1M303,8575.1%
Profound MED Corp(PROF)COM NEW74319B502$2.1M360,5895.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$2.0M60,2514.9%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$1.7M1,050,3694.0%
Skye Bioscience Inc(SKYE)COM NEW83086J200$1.4M904,8653.5%
Alpha Cognition Inc(ACOG)COM NEW02074J501$897.7K177,4162.2%
Rezolute Inc(RZLT)COM NEW76200L309$881.5K303,9492.1%
Nektar Therapeutics(NKTREUR)COM640268108$714.9K1,051,3791.7%
Anteris Technologies Global(AVR)COM03675P102$613.7K168,5891.5%
Larimar Therapeutics Inc(LRMR)COM517125100$587.4K273,2041.4%
Promis Neurosciences Inc(PMNEUR)COM NEW74346M406$399.4K574,2481.0%
Envveno Medical CorporationCOM29415J106$324.2K123,2560.8%
Xenon Pharmaceuticals Inc(XENE)CallCOM98420N105$315.4K9,4000.8%
Intelligent BIO Solutions in(GBS1EUR)COM36151G600$214.9K149,2520.5%
Karyopharm Therapeutics Inc(KPTI)COM NEW48576U205$184.5K49,3330.4%
Sharps Technology IncACOM NEW82003F200$110.4K4,044,1490.3%
Logicmark IncACOM NEW67091J602$106.8K5,395,3080.3%
Sunshine Biopharma Inc(SBFM)COM867781700$96.4K50,4660.2%
Better Choice Co Inc(SRXH)COM NEW08771Y402$67.1K38,9840.2%